Cerebrospinal Fluid

Chapter
Part of the Essentials in Cytopathology book series (EICP, volume 11)

Abstract

The lumbar puncture (spinal tap) was introduced in 1891, and in 1904 a French neurologist first described malignant cells in cerebrospinal fluid (CSF). Since then, preparatory methods have been refined and diagnostic features described in a number of monographs and atlases, attesting to the importance of CSF cytology for excluding leptomeningeal metastasis in a patient with neurologic symptoms.

Keywords

Lymphoma Leukemia Adenoma Meningioma Hydrocephalus 

Selected References

  1. Ahmed SV, Jayawarna C, Jude E. Post lumbar puncture headache: diagnosis and management. Postgrad Med J. 2006;82(973):713–6.PubMedCrossRefGoogle Scholar
  2. Aichner F, Schuler G. Primary leptomeningeal melanoma: diagnosis by ultrastructural cytology of cerebrospinal fluid and cranial computed tomography. Cancer. 1982;50:1751–6.PubMedCrossRefGoogle Scholar
  3. Balhuizen JC, Bots GT, Schaberg A, et al. Value of cerebrospinal fluid cytology for the diagnosis of malignancies in the central nervous system. J Neurosurg. 1978;48:747–53.PubMedCrossRefGoogle Scholar
  4. Barshes N, Demopoulos A, Engelhard HH. Anatomy and physiology of the leptomeninges and CSF space. Cancer Treat Res. 2005;125:1–16.PubMedCrossRefGoogle Scholar
  5. Bigner SH, Johnston WW. The diagnostic challenge of tumors manifested initially by the shedding of cells into cerebrospinal fluid. Acta Cytol. 1984;28:29–36.PubMedGoogle Scholar
  6. Bigner SH, Johnston WW. Cytopathology of the central nervous system. Chicago: American Society of Clinical Pathologists Press; 1994.Google Scholar
  7. Bonnín JM, Garcia JH. Primary malignant non-Hodgkin’s lymphoma of the central nervous system. Pathol Annu. 1987;22:353–75.PubMedGoogle Scholar
  8. Boogerd W, Vroom TM. Meningeal involvement as the initial symptom of B cell chronic lymphocytic leukemia. Eur Neurol. 1986;25:461–4.PubMedCrossRefGoogle Scholar
  9. Boogerd W, Vroom TM, Van Heerde P, et al. CSF cytology versus immunocytochemistry in meningeal carcinomatosis. J Neurol Neurosurg Psychiatry. 1988;51:142–5.PubMedCrossRefGoogle Scholar
  10. Borowitz MJ, DiGiuseppe JA. Acute lymphoblastic leukemia. In: Knowles DM, editor. Neoplastic hematopathology. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 1643–65.Google Scholar
  11. Borowitz M, Bigner SH, Johnston WW. Diagnostic problems in the cytologic evaluation of cerebrospinal fluid for lymphoma and leukemia. Acta Cytol. 1981;25:665–74.PubMedGoogle Scholar
  12. Breuer AC, Tyler HR, Marzewski DJ, et al. Radicular vessels are the most probable source of needle induced blood in lumbar puncture: significance for the thrombocytopenic cancer patient. Cancer. 1982;49:2168–72.PubMedCrossRefGoogle Scholar
  13. Brogi E, Cibas ES. Cytologic detection of Toxoplasma gondii tachyzoites in cerebrospinal fluid. Am J Clin Pathol. 2000;114:951–5.PubMedCrossRefGoogle Scholar
  14. Browne TJ, Goumnerova LC, De Girolami U, et al. Cytologic features of pilocytic astrocytoma in cerebrospinal fluid specimens. Acta Cytol. 2004;48(1):3–8.PubMedCrossRefGoogle Scholar
  15. Brunning RD. Acute myeloid leukemia. In: Knowles DM, editor. Neoplastic hematopathology. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 1667–715.Google Scholar
  16. Buchino JJ, Mason KG. Choroid plexus papilloma: report of a case with cytologic differential diagnosis. Acta Cytol. 1992;36:95–7.PubMedGoogle Scholar
  17. Chamberlain MC. Neoplastic meningitis. Semin Neurol. 2004;24(4):363–74.PubMedCrossRefGoogle Scholar
  18. Chan TY, Parwani AV, Levi AW, et al. Mollaret’s meningitis: cytopathologic analysis of fourteen cases. Diagn Cytopathol. 2003;28(5):227–31.PubMedCrossRefGoogle Scholar
  19. Chen KT, Moseley D. Cartilage cells in cerebrospinal fluid. Arch Pathol Lab Med. 1990;114:212.PubMedGoogle Scholar
  20. Chhieng DC, Elgert P, Cohen JM, et al. Cytology of primary central nervous system neoplasms in cerebrospinal fluid specimens. Diagn Cytopathol. 2002;26(4):209–12.PubMedCrossRefGoogle Scholar
  21. Csako G, Chandra P. Bronchioloalveolar carcinoma presenting with meningeal carcinomatosis: cytologic diagnosis in cerebrospinal fluid. Acta Cytol. 1986;30:653–6.PubMedGoogle Scholar
  22. D’Andrea AD, Packer RJ, Rorke LB, et al. Pineocytomas of childhood: a reappraisal of natural history and response to therapy. Cancer. 1987;59:1353–7.PubMedCrossRefGoogle Scholar
  23. Davies SF, Gormus BJ, Yarchoan R, et al. Cryptococcal meningitis with false-positive cytology in the CSF: use of T-cell rosetting to exclude meningeal lymphoma. JAMA. 1978;22:2369–70.CrossRefGoogle Scholar
  24. De Reuck J, Vanderdonckt P. Choroid plexus and ependymal cells in CSF cytology. Clin Neurol Neurosurg. 1986;88:177–9.PubMedCrossRefGoogle Scholar
  25. De Reuck J, Vanderdonckt P, de Bleecker J, et al. Mitotic activity in cerebrospinal fluid cells. Clin Neurol Neurosurg. 1988;90:117–9.PubMedCrossRefGoogle Scholar
  26. DeAngelis LM, Boutros D. Leptomeningeal metastasis. Cancer Invest. 2005;23(2):145–54.PubMedCrossRefGoogle Scholar
  27. DeGirolami U, Schmidek H. Clinicopathological study of 53 tumors of the pineal region. J Neurosurg. 1973;9:455–62.Google Scholar
  28. Dufour H. Méningite sarcomateuse diffuse avec envahissement de la Moelle et des Racines: cytologie positive et spéciale du liquide céphalorachidien. Rev Neurol. 1904;12:104–6.Google Scholar
  29. Duma RJ, Ferrell HW, Nelson EC, et al. Primary amebic meningoencephalitis. N Engl J Med. 1969;281:1315–23.PubMedCrossRefGoogle Scholar
  30. Dyken PR. Cerebrospinal fluid cytology: practical clinical usefulness. Neurology. 1975;25:210–7.PubMedGoogle Scholar
  31. Enting RH. Leptomeningeal neoplasia: epidemiology, clinical presentation, CSF analysis and diagnostic imaging. Cancer Treat Res. 2005;125:17–30.PubMedCrossRefGoogle Scholar
  32. Finn WG, Peterson LC, James C, et al. Enhanced detection of malignant lymphoma in cerebrospinal fluid by multiparameter flow cytometry. Am J Clin Pathol. 1988;110:3416.Google Scholar
  33. Fischer JR, Davey DD, Gulley ML, et al. Blast-like cells in cerebrospinal fluid of neonates: possible germinal matrix origin. Am J Clin Pathol. 1989;91:255–8.PubMedGoogle Scholar
  34. Fishman RA. Cerebrospinal fluid in diseases of the nervous system. 2nd ed. Philadelphia: WB Saunders; 1992.Google Scholar
  35. French CA, Dorfman DM, Shaheen G, et al. Diagnosing lymphoproliferative disorders involving the cerebrospinal fluid: increased sensitivity using flow cytometric analysis. Diagn Cytopathol. 2000;23:369–74.PubMedCrossRefGoogle Scholar
  36. Gétaz EP, Miller GJ. Spinal cord involvement in chronic lymphocytic leukemia. Cancer. 1979;43:1858–61.PubMedCrossRefGoogle Scholar
  37. Gindhart TD, Tsukahara YC. Cytologic diagnosis of pineal germinoma in cerebrospinal fluid and sputum. Acta Cytol. 1979;23:341–6.PubMedGoogle Scholar
  38. Glantz MJ, Cole BF, Glantz LK, et al. Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results. Cancer. 1998;82(4):733–9.PubMedCrossRefGoogle Scholar
  39. Glass JP, Melamed M, Chernik NL, et al. Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology. 1979;29:1369–75.PubMedGoogle Scholar
  40. Gondos B, King EB. Cerebrospinal fluid cytology: diagnostic accuracy and comparison of different techniques. Acta Cytol. 1976;20:542–7.PubMedGoogle Scholar
  41. Granter SR, Doolittle MH, Renshaw AA. Predominance of neutrophils in the cerebrospinal fluid of AIDS patients with cytomegalovirus radiculopathy. Am J Clin Pathol. 1996;105:364–6.PubMedGoogle Scholar
  42. Gupta PK, Gupta PC, Roy S, et al. Herpes simplex encephalitis, cerebrospinal fluid cytology studies: two case reports. Acta Cytol. 1972;16:563–5.PubMedGoogle Scholar
  43. Hajdu SI, Ashton PR, Carter D, et al. Diagnostic cytology seminar. Acta Cytol. 1982;26:874–6.Google Scholar
  44. Health and Public Policy Committee, American College of Physicians. The diagnostic spinal tap. Ann Intern Med. 1986;104:880–5.Google Scholar
  45. Herrick MK, Rubinstein LJ. The cytological differentiating potential of pineal parenchymal neoplasms (true pinealomas): a clinicopathological study of 28 tumors. Brain. 1979;102:289–320.PubMedCrossRefGoogle Scholar
  46. Jaffe ES, Harris NL, Stein M, et al., editors. World Health Organization classification of tumours. Pathology and genetics of tumours and haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001.Google Scholar
  47. Jaffey PB, Varma SK, DeMay RM, et al. Blast-like cells in the cerebrospinal fluid of young infants: further characterization of clinical setting, morphology, and origin. Am J Clin Pathol. 1996;105:544–7.PubMedGoogle Scholar
  48. Jereb B, Reid A, Ahuja RK. Patterns of failure in patients with medulloblastoma. Cancer. 1982;50:2941–7.PubMedCrossRefGoogle Scholar
  49. Kamiya M, Tateyama H, Fujiyoshi Y, et al. Cerebrospinal fluid cytology in immature teratoma of the central nervous system: a case report. Acta Cytol. 1991;35:757–60.PubMedGoogle Scholar
  50. Kaplan JG, DeSouza TG, Farkash A, et al. Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias. J Neurooncol. 1990;9(3):225–9.PubMedCrossRefGoogle Scholar
  51. Kim K, Greenblatt SH, Robinson MG. Choroid plexus carcinoma: report of a case with cytopathologic differential diagnosis. Acta Cytol. 1985;29:846–9.PubMedGoogle Scholar
  52. Kjeldsberg CR, Knight JA. Body fluids: laboratory examination of amniotic, cerebrospinal, seminal, serous, and synovial fluids. 3rd ed. Chicago: American Society of Clinical Pathologists Press; 1993.Google Scholar
  53. Kleihues P, Cavenee W, editors. Pathology and genetics of tumours of the nervous system. Lyon: IARC Press; 2000.Google Scholar
  54. Kruskall MS, Carter SR, Ritz LP. Contamination of cerebrospinal fluid by vertebral bone marrow cells during lumbar puncture. N Engl J Med. 1983;308(12):697–700.PubMedCrossRefGoogle Scholar
  55. Kuberski T. Eosinophils in the cerebrospinal fluid. Ann Intern Med. 1979;91:70–5.PubMedGoogle Scholar
  56. Lachance DH, O’Neill BP, Macdonald DR, et al. Primary leptomeningeal lymphoma: report of 9 cases, diagnosis with immunocytochemical analysis, and review of the literature. Neurology. 1991;41(1):95–100.PubMedGoogle Scholar
  57. Leiman G, Klein C, Berry AV. Cells of nucleus pulposus in cerebrospinal fluid. A case report. Acta Cytol. 1980;24:347–9.PubMedGoogle Scholar
  58. Li CY, Witzig TE, Phyliky RL, et al. Diagnosis of B-cell non-Hodgkin’s lymphoma of the central nervous system by immunocytochemical analysis of cerebrospinal fluid lymphocytes. Cancer. 1986;57:737–44.PubMedCrossRefGoogle Scholar
  59. Liepman MK, Votaw ML. Meningeal leukemia complicating chronic lymphocytic leukemia. Cancer. 1981;47:2482–4.PubMedCrossRefGoogle Scholar
  60. Ludwin SK, Conley FK. Malignant meningioma metastasizing through the cerebrospinal pathways. J Neurol Neurosurg Psychiatry. 1975;38:136–42.PubMedCrossRefGoogle Scholar
  61. Mattu R, Sorbara L, Filie AC, et al. Utilization of polymerase chain reaction on archival cytologic material: a comparison with fresh material with special emphasis on cerebrospinal fluids. Mod Pathol. 2004;17(10):1295–301.PubMedCrossRefGoogle Scholar
  62. Meyer RJ, Ferreira PP, Cuttner J, et al. Central nervous system involvement at presentation in acute granulocytic leukemia: a prospective cytocentrifuge study. Am J Med. 1980;68:691–4.PubMedCrossRefGoogle Scholar
  63. Miller RR, Lin F, Mallonee MM. Cytologic diagnosis of gliomatosis cerebri. Acta Cytol. 1981;25:37–9.PubMedGoogle Scholar
  64. Morrison C, Shah S, Flinn IW. Leptomeningeal involvement in chronic lymphocytic leukemia. Cancer Pract. 1998;6(4):223–8.PubMedCrossRefGoogle Scholar
  65. Naylor B. The cytologic diagnosis of cerebrospinal fluid. Acta Cytol. 1964;8:141–9.PubMedGoogle Scholar
  66. NCCLS. Nongynecologic cytologic specimens: collection and cytopreparatory techniques; Approved guideline. NCCLS document GP23-A. Wayne: NCCLS; 1999.Google Scholar
  67. Nolan CP, Abrey LE. Leptomeningeal metastases from leukemias and lymphomas. Cancer Treat Res. 2005;125:53–69.PubMedCrossRefGoogle Scholar
  68. Nuckols JD, Liu K, Burchette J, et al. Primary central nervous system lymphomas: a 30 year experience at a single institution. Mod Pathol. 1999;12:1167–73.PubMedGoogle Scholar
  69. Ogilvy KM, Jakubowski J. Intracranial dissemination of pituitary adenomas. J Neurol Neurosurg Psychiatry. 1973;36:199–205.PubMedCrossRefGoogle Scholar
  70. Packer RJ, Siegel KR, Sutton LN, et al. Leptomeningeal dissemination of primary central nervous system tumors of childhood. Ann Neurol. 1985;18:217–21.PubMedCrossRefGoogle Scholar
  71. Page R, Doshi B, Sharr MM. Primary intracranial choriocarcinoma. J Neurol Neurosurg Psychiatry. 1986;49:93–5.PubMedCrossRefGoogle Scholar
  72. Prayson RA, Fischler DF. Cerebrospinal fluid: an 11-year experience with 5951 specimens. Arch Pathol Lab Med. 1998;122:47–57.PubMedGoogle Scholar
  73. Price RA, Johnson WW. The central nervous system in childhood leukemia: I. The arachnoid. Cancer. 1973;31:520–33.PubMedCrossRefGoogle Scholar
  74. Qian X, Cibas ES, Goumnerova L, et al. Cerebrospinal fluid findings in patients with ependymal neoplasms: a bi-institutional retrospective study of 50 cases. Acta Cytol. 2003;47:826–7.CrossRefGoogle Scholar
  75. Quincke H. Die Lumbarpunktion des Hydrocephalus. Klin Wochenschr. 1891;28(929–933):965–8.Google Scholar
  76. Ringenberg QS, Francis R, Doll DC. Meningeal carcinomatosis as the presenting manifestation of tumors of unknown origin. Acta Cytol. 1990;34:590–2.PubMedGoogle Scholar
  77. Rogers LR, Duchesneau PM, Nunez C, et al. Comparison of cisternal and lumbar CSF examination in leptomeningeal metastasis. Neurology. 1992;42(6):1239–41.PubMedGoogle Scholar
  78. Rohlfing MB, Barton TK, Bigner SH, et al. Contamination of cerebrospinal fluid specimens with hematogenous blasts in patients with leukemia. Acta Cytol. 1981;25:611–5.PubMedGoogle Scholar
  79. Ross JS, Magro C, Szyfelbein W, et al. Cerebrospinal fluid pleocytosis in aseptic meningitis: cytomorphic and immunocytochemical features. Diagn Cytopathol. 1991;7(5):532–5.PubMedCrossRefGoogle Scholar
  80. Schmidt P, NeuenJacob E, Blanke M, et al. Primary malignant melanoblastosis of the meninges: clinical, cytologic and neuropathologic findings in a case. Acta Cytol. 1988;32:713–8.PubMedGoogle Scholar
  81. Schwartz JH, Canellos GP, Young RC, et al. Meningeal leukemia in the blastic phase of chronic granulocytic leukemia. Am J Med. 1975;9:819–28.CrossRefGoogle Scholar
  82. Sciarra D, Carter S. Lumbar puncture headache. JAMA. 1952;148:841–2.CrossRefGoogle Scholar
  83. Scully RE, Mark EJ, McNeely WF, et al. Case records of the Massachusetts General Hospital. Case 321987. N Engl J Med. 1987;317:366–75.CrossRefGoogle Scholar
  84. Shenkier TN. Unusual variants of primary central nervous system lymphoma. Hematol Oncol Clin North Am. 2005;19(4):651–64, vi.Google Scholar
  85. Shibata D, Nichols P, Sherrod A, et al. Detection of occult CNS involvement of follicular small cleaved lymphoma by the polymerase chain reaction. Mod Pathol. 1990;3:71–5.PubMedGoogle Scholar
  86. Stefanko SZ, Talerman A, Mackay WM, et al. Infundibular germinoma. Acta Neurochir. 1979;50:71–8.CrossRefGoogle Scholar
  87. Szyfelbein WM, Ross JS. Lyme disease meningopolyneuritis simulating malignant lymphoma. Mod Pathol. 1988;1:464–8.PubMedGoogle Scholar
  88. Takeuchi J, Handa H, Nagata I. Suprasellar germinoma. J Neurosurg. 1978;49:41–8.PubMedCrossRefGoogle Scholar
  89. Tedder DG, Ashley R, Tyler KL, et al. Herpes simplex virus infection as a cause of benign recurrent lymphocytic meningitis. Ann Intern Med. 1994;121:334–8.PubMedGoogle Scholar
  90. Torzewski M, Lackner K, Bohl J, et al. Integrated cytology of cerebrospinal fluid. New York: Springer; 2008.Google Scholar
  91. Trojanowski JQ, Atkinson B, Lee VM. An immunocytochemical study of normal and abnormal human cerebrospinal fluid with monoclonal antibodies to glial fibrillary acidic protein. Acta Cytol. 1986;30:235–9.PubMedGoogle Scholar
  92. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;100(7):2292–302.PubMedCrossRefGoogle Scholar
  93. Walts AE. Cerebrospinal fluid cytology: selected issues. Diagn Cytopathol. 1992;8:394–408.PubMedCrossRefGoogle Scholar
  94. Wasserstrom WR, Glass JP, Posner JB. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer. 1982;49:759–72.PubMedCrossRefGoogle Scholar
  95. Watson CW, Hajdu SI. Cytology of primary neoplasms of the central nervous system. Acta Cytol. 1977;21:40–7.PubMedGoogle Scholar
  96. Wechsler LR, Gross RA, Miller DC. Meningeal gliomatosis with “negative” CSF cytology: the value of GFAP staining. Neurology. 1984;34:1611–5.PubMedGoogle Scholar
  97. Weller PF, Liu LX. Eosinophilic meningitis. Semin Neurol. 1993;13:161–8.PubMedCrossRefGoogle Scholar
  98. Wertlake PT, Markovits BA, Stellar S. Cytologic evaluation of cerebrospinal fluid with clinical and histologic correlation. Acta Cytol. 1972;6:229–39.Google Scholar
  99. Wynter W. Four cases of tubercular meningitis in which paracentesis of the theca vertebralis was performed for the relief of fluid pressure. Lancet. 1891;1:981–2.CrossRefGoogle Scholar
  100. Yamamoto LJ, Tedder DG, Ashley R, et al. Herpes simplex virus type I DNA in cerebrospinal fluid of a patient with Mollaret’s meningitis. N Engl J Med. 1991;325:1082–5.PubMedCrossRefGoogle Scholar
  101. Zeman D, Adam P, Kalistova H, et al. Cerebrospinal fluid cytologic findings in multiple sclerosis. A comparison between patient subgroups. Acta Cytol. 2001;45:51–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of PathologyThe Johns Hopkins HospitalBaltimoreUSA
  2. 2.Department of Pathology Brigham and Women’s HospitalHarvard Medical SchoolBostonUSA

Personalised recommendations